BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24440234)

  • 1. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent.
    Ojha R; Singh SK; Bhattacharyya S; Dhanda RS; Rakha A; Mandal AK; Jha V
    J Urol; 2014 Jun; 191(6):1889-98. PubMed ID: 24440234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging immunotherapies for bladder cancer.
    Kim JW; Tomita Y; Trepel J; Apolo AB
    Curr Opin Oncol; 2015 May; 27(3):191-200. PubMed ID: 25811346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for treating relapsed/refractory urothelial carcinoma.
    Iyer G; Milowsky MI; Bajorin DF
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1917-32. PubMed ID: 21110758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics.
    Liu K; Chen H; Li Y; Wang B; Li Q; Zhang L; Liu X; Wang C; Ertas YN; Shi H
    Cancer Lett; 2024 Jun; 591():216867. PubMed ID: 38593919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells.
    Huang Z; Wang T; Xia W; Li Q; Chen X; Liu X; Wei P; Xu W; Lv M
    Exp Ther Med; 2020 Aug; 20(2):1431-1440. PubMed ID: 32765672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy modulation changes mechano-chemical sensitivity of T24 bladder cancer cells.
    Jobst M; Hossain M; Kiss E; Bergen J; Marko D; Del Favero G
    Biomed Pharmacother; 2024 Jan; 170():115942. PubMed ID: 38042111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic lethality in human bladder cancer cells by curcumin via concurrent Aurora A inhibition and autophagy induction.
    Fan YW; Lu IC; Hsu MY; Kuo WT; Wu SY; Lan SH; Wang PY; Chen CY; Liu HS; Su CL
    J Nutr Biochem; 2023 Nov; 121():109438. PubMed ID: 37666476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition.
    Wang X; Li Y; Lu J; Deng X; Wu Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmenting Tumor-Starvation Therapy by Cancer Cell Autophagy Inhibition.
    Yang B; Ding L; Chen Y; Shi J
    Adv Sci (Weinh); 2020 Mar; 7(6):1902847. PubMed ID: 32195096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagic cell death RIPs into tumors.
    Oberst A
    Cell Death Differ; 2013 Sep; 20(9):1131-2. PubMed ID: 23933887
    [No Abstract]   [Full Text] [Related]  

  • 11. The Potent Anti-Tumor Effects of Rhodiola Drinking Are Associated with the Inhibition of the mTOR Pathway and Modification of Tumor Metabolism in the UPII-Mutant Ha-Ras Model.
    Liu Z; Yokoyama NN; Song L; Xie J; Sadeghi Z; Wu YX; Yee S; Wu XR; Wang B; Uchio E; Zi X
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370698
    [No Abstract]   [Full Text] [Related]  

  • 12. Unlocking precision oncology with FGFR inhibition in urothelial carcinoma.
    Sonpavde GP; Subbiah V
    Ann Oncol; 2024 Feb; 35(2):150-153. PubMed ID: 37981237
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study.
    Mudrabettu C; Kumar V; Rakha A; Yadav AK; Ramachandran R; Kanwar DB; Nada R; Minz M; Sakhuja V; Marwaha N; Jha V
    Nephrology (Carlton); 2015 Jan; 20(1):25-33. PubMed ID: 25230334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.
    Yu H; Zhuang J; Zhou Z; Song Q; Lv J; Yang X; Yang H; Lu Q
    Int J Biol Sci; 2024; 20(4):1471-1491. PubMed ID: 38385084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer.
    Tantray I; Ojha R; Sharma AP
    Front Genet; 2022; 13():1051762. PubMed ID: 36685879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update to Hallmarks of Cancer.
    Ravi S; Alencar AM; Arakelyan J; Xu W; Stauber R; Wang CI; Papyan R; Ghazaryan N; Pereira RM
    Cureus; 2022 May; 14(5):e24803. PubMed ID: 35686268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth
    Du H; Tao T; Xu S; Xu C; Li S; Su Q; Yan J; Liu B; Li R
    Front Mol Biosci; 2021; 8():789658. PubMed ID: 35252345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan.
    Lai HY; Wu LC; Kong PH; Tsai HH; Chen YT; Cheng YT; Luo HL; Li CF
    Front Oncol; 2021; 11():828314. PubMed ID: 35071023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder.
    Singh A; Gupta N; Khandakar H; Kaushal S; Seth A; Pandey RM; Sharma A
    Mol Cell Biochem; 2022 Feb; 477(2):493-505. PubMed ID: 34796446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming.
    Li T; Tong H; Yin H; Luo Y; Zhu J; Qin Z; Yin S; He W
    Cancer Cell Int; 2021 Nov; 21(1):597. PubMed ID: 34743698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.